Avenue Therapeutics

New York, United States

Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.

$5.0M raised

Oct 2023

Post-IPO Equity

Biotechnology Health Care Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Avenue Therapeutics

How much funding has Avenue Therapeutics raised?

Avenue Therapeutics has raised $5.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2023.

Where is Avenue Therapeutics headquartered?

Avenue Therapeutics is headquartered in New York, United States.

What does Avenue Therapeutics do?

Avenue Therapeutics is a specialty pharmaceutical company that acquires/in-licenses, develops and commercializes products.

What stage is Avenue Therapeutics at?

Avenue Therapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 31, 2023.

MLA

"Avenue Therapeutics — Funding & Investors." VCBacked, October 31, 2023, https://www.vcbacked.co/company/avenue-therapeutics. Accessed July 5, 2026.

APA

VCBacked. (2023). Avenue Therapeutics — Funding & Investors. Retrieved July 5, 2026, from https://www.vcbacked.co/company/avenue-therapeutics

Wikipedia (cite web)

{{cite web |title=Avenue Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/avenue-therapeutics |website=VCBacked |access-date=July 5, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 31, 2023.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K